Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA - Lenderink,T.; Boersma,E.; Heeschen,C. (Eur Heart J, 2003)